Palm Beach Gardens, Fla.-based spinal implant medical technology company Accelus has received regulatory approval in Brazil for its FlareHawk Interbody Fusion System. The Brazilian Health Regulatory ...

A neurosurgeon and a neuroscientist discover promising new ways to help people with spinal cord injuries walk again ...

Stryker Corp. plans to sell its U.S. spinal implant business to a New York-based family office Viscogliosi Brothers LLC.

Barclays analyst Matt Miksic raised the firm’s price target on Stryker (SYK) to $443 from $418 and keeps an Overweight rating on the shares.

Barclays analyst Matt Miksic maintained a Buy rating on Stryker (SYK – Research Report) today and set a price target of $443.00. The company’s ...

We recently published a list of 12 Best Automation Stocks To Buy According to Hedge Funds. In this article, we are going to ...

Researchers reported a spine-stimulating implant might aid neurodegenerative diseases like spinal muscle atrophy.

From FDA approvals to medical milestones, here are four key developments from spine and orthopedic medtech companies since Jan. 29.

PORTAGE, Michigan - Medical (TASE:PMCN) technology firm Stryker Corporation (NYSE:SYK), with a market capitalization of $149.59 billion, has announced an increase in its quarterly dividend. Today, the ...

Orthopedic Implants Market Trends 2025 Increase in the prevalence of orthopedic injuries or diseases such as arthritis and osteoarthritis & ...